HOME › DRUGS › FARICIMAB
ACTIVE SUBSTANCE / INN

FARICIMAB

Brand name(s): Vabysmo
EMA LISTED
AUTHORISED
Wet Macular Degeneration;Macular Edema;Diabetes Complication…
ACTIVE SUBSTANCE
Faricimab
REGULATORS
EMA
SPONSORS / MAH
Roche Registration GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VabysmoRoche Registration GmbHAuthorised15/09/2022Wet Macular Degeneration;Macular Edema;Diabetes Complications

FULL INTELLIGENCE ON FARICIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →